Citi keeps a Neutral rating on Carlyle Group with a $45 price target and opened a “90-day positive catalyst watch” on the shares, expecting the company’s fundraising trends to improve over the coming months. The environment for the alternative asset managers improved modestly in Q2 relative to Q1, with deployment activity picking up, the analyst tells investors in a research note. However, fundraising “remains in a lower gear, and monetization activity remains sporadic,” adds Citi. The firm’s favorite names at the moment are Blue Owl Capital (OWL) and Apollo Global (APO).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CG:
- Carlyle price target lowered to $41 from $45 at TD Cowen
- Baxter up 5% after WSJ report on Carlyle talks to buy kidney care unit
- Carlyle in talks to buy Baxter’s Vantive business for over $4B, WSJ reports
- Carlyle in advanced talks to buy Baxter’s Vantive business, WSJ reports
- Carlyle, KKR win $10B Discover Financial loan portfolio, FT reports